FDA Adverse Event Injury Summary report: N

VANGUARD COMPLETE KNEE SYSTEM - TIB BRG 63/67X12

MDR report key: 6676315 · Received June 29, 2017

Report

Report Number
0001825034-2017-04449
Event Type
Injury
Date Received
June 29, 2017
Date of Event
August 24, 2015
Report Date
September 30, 2017
Manufacturer
BIOMET ORTHOPEDICS
Product Code
JWH
PMA / PMN Number
PK113550
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: REGENEREX 34MM PATELLA CATALOG 141357 LOT 344230; VANGUARD FEMUR RIGHT 60MM CATALOG 183044 LOT 386610; REGENEREX TIBIAL TRAY 67MM CATALOG 141272 LOT 299140; MODULAR SPLINED STEM 40MM CATALOG 141369 LOT 454860. CUSTOMER HAS NOT INDICATED THAT THE PRODUCT WILL BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 1822565-2017-03198, 1825034-2017-04449, 1825034-2017-04446, 1825034-2017-04447, AND 1825034-2017-04448.

Additional Manufacturer Narrative · 1

THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A RIGHT TOTAL KNEE REVISION APPROXIMATELY ONE YEAR POST IMPLANTATION DUE TO UNKNOWN REASONS. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
457166 VANGUARD COMPLETE KNEE SYSTEM - TIB BRG 63/67X12 PROSTHESIS, KNEE JWH BIOMET ORTHOPEDICS 911000

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| R